Article 6DY5B Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION

Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION

by
from Morbidity and Mortality Weekly Report (MMWR) on (#6DY5B)
This report describes the effectiveness of monovalent and bivalent mRNA COVID-19 vaccines among children 6 months-5 yearsThis report describes the effectiveness of monovalent and bivalent mRNA COVID-19 vaccines among children 6 months-5 years
External Content
Source RSS or Atom Feed
Feed Location http://www2c.cdc.gov/podcasts/createrss.asp?t=r&c=5
Feed Title Morbidity and Mortality Weekly Report (MMWR)
Feed Link https://www.cdc.gov/mmwr/index.html
Reply 0 comments